FDA Inspection 1055322 — Clinical Laboratories of Hawaii, LLP
The FDA completed an inspection of Clinical Laboratories of Hawaii, LLP on May 17, 2018 in Honolulu, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 17, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Honolulu, HI (United States)